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BIOPOTENTIALS OF ULVA FASCIATA AND
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ABSTRACT
The secondary metabolites of seaweeds Ulva fasciata and Hypnea
musciformis, collected form southeast and southwest coast of India,
were tested for biotoxicity potential. Both species showed potent
activity in antibacterial, brine shrimp cytotoxicity, larvicidal, antifouling and ichthyotoxicity assays. The green alga U. fasciata
exhibited broad-spectrum antibacterial activity whereas the red alga
H. musciformis showed narrow spectrum antibacterial activity. The
brine shrimp cytotoxicity profile indicated that the seaweeds were
moderately toxic. The overall activity profile indicated that U.
fasciata contained more biological potency than H. musciformis.

INTRODUCTION
Marine algae are not only the primary and major
producers of organic matter in the sea, but they also
exert profound effects on the density and distribution of
other inhabitants of the marine environment. An understanding of the wide range of behavioural relationships
that exist among organisms would provide us with clues
to substances of biomedical interest. Marine secondary
metabolites are organic compounds produced by
microbes, sponges, seaweeds, and other marine
organisms. The host organism biosynthesizes these
compounds as non-primary or secondary metabolites to
protect themselves and to maintain homeostasis in their
environment. Some of these secondary metabolites
offer avenues for developing cost-effective, safe and
potent drugs. Nearly 50 lakhs (50,000,00) species
available in the sea are virtually untapped sources of
secondary metabolites. Those compounds already iso-
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lated from seaweeds are providing valuable ideas for the
development of new drugs against cancer, microbial
infections and inflammation (Elena et al., 2001; Kim et
al., 1997; Okai et al., 1997; Premila et al., 1996) apart
from their potential ecological/industrial significances
such as controlling reproduction, settlement/biofouling
and feeding deterrents (Selvin, 2002). In this
background, the present study intended to evaluate the
toxic influence, activity range and potency of seaweeds
collected from the peninsular coast of India.
MATERIALS AND METHODS
The algae, which inhabited exclusively on the
intertidal rocky substratum, were selected for the collection in order to avoid other algal contamination
(Selvin, 2002). Predominant algae such as Ulva fasciata
and Hypnea musciformis were collected along the southeast and southwest of India. Immediately after collection,
they were washed in fresh seawater to remove the
epiphytes, sand and other extraneous matter and airdried under shade. Completely dried material was
weighed and ground finely in a mechanical grinder. The
secondary metabolites of seaweeds were extracted in
bulk extraction process. In this process, 500 g of finely
powdered algal material was refluxed in a 5 L capacity
round bottom flask using methanol-dichloromethane
(1:1). The extract was filtered and concentrated to
recover the excess solvents in another distillation system.
Finally it was reduced to thick oily natured crude extract
in a rotary vacuum evaporator (Buchi) at 40°C.
Modified cylinder plate double layer method was
used for the evaluation of antibacterial potential of
seaweeds. The following bacterial strains were used as
test organism (i) Seven type cultures (obtained from
Microbial Type Culture Collections, Chandigargh,
India): Micrococcus luteus (ML), Bacillus cereus (BC),
Bacillus subtilis (BS), Escherichia coli (EC), Aeromonas
hydrophila (AH), Pseudomonas aeruginosa (PA), and
Vibrio fischeri (VF), (ii) two shrimp isolates: Vibrio
alginolyticus (QS7) and Vibrio harveyi (RJM5) (iii) two
fish isolates: Aeromonas sp. (CF-1) and Aeromonas sp.
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(CF-2). The inoculum was prepared by adding 5 ml of
sterile nutrient broth onto the 18 h fresh slant culture of
appropriate bacterium. The tube was gently vortexed
and the suspension was collected in a sterile test tube.
The first base layer was prepared with 10 mL of 1.5%
agar. Six numbers of sterile porcelain beads of 7 mm
diameter was placed on the base layer. The overlaid
seed layer was prepared by pouring 15 mL of hot nutrient agar containing 0.2 ml of prepared inoculum (USP
1995; IP 1996; HiMedia Manual, 1998). After the seed
layer solidified, the porcelain beads were removed
carefully with a sterile forceps. The resultant wells
were filled with 100 µL of the appropriate algal extract
and vehicle control (VC). After 24 h of incubation at
37 ± 2°C the area of inhibition zone was determined as
average of triplicates.
Brine shrimp cytotoxicity assay was performed
using the freshly hatched free-swimming nauplii of
Artemia salina. The assay system was prepared with 2
mL of filtered seawater containing chosen concentration of extract in cavity blocks (embryo cup) and 20
nauplii each was transferred in experimental, vehicle
control and negative control wells. Invariably the concentration of the experimental systems was determined
on the basis of exploratory experiments. Based on the
percent mortality, the LD 50 of the test compound was
determined using probit scale (Miller and Tainter, 1944).
The susceptibility or resistance of the mosquito larvae
(Culex sp.) to the selected concentration of the extracts
was carried out by adopting standard bioassay protocol
(WHO, 1981). Observations were made after 24 h of
treatment for larvicidal activity. The anticoagulant activity was studied using whole blood clotting time method
(Selvin, 2002). Fingerlings (1.5-2.0 cm) of marine
acclimated Oreochromis mossambicus were used for
evaluating the ichthyotoxic potential. Five fingerlings
each were introduced in experimental and control glass
bowls containing 1,000 mL seawater and chosen concentrations of extract. Immediate reflex changes and
mortality were observed continuously for six hours at 1
h interval for the next 12 h. After 24 h of exposure, the
number dead and live fish were counted. The acute
toxicological reflexes were observed and recorded (Indap
and Pathare, 1998). Antifouling activity of secondary
metabolites was evaluated using newly developed ‘mol-

lusc foot adherence bioassay’ (Selvin and Lipton, 2002).
One of the common rock fouler Patella vulgata was
used as test organism.
RESULTS AND DISCUSSION
The green alga Ulva fasciata exhibited broad spectrum of antibacterial activity and its extract inhibited all
the tested bacteria in different activity ranges. The red
alga Hypnea musciformis showed narrow spectrum of
activity as it successfully prevented the growth of gram
positive bacteria more significantly than the gram
negative strains (Table 1). H. musciformis extract inhibited the growth of gram positive strains to the extent
of 66.0% at 30°C, whereas all the gram positive bacteria
were susceptible at 20°C. However, the inhibitory
potential was feeble towards the gram-negative strains
and only 50% and 75% at 30 and 20°C, respectively,
were inhibited. Based on the inhibition area, the activity range was classified as less active, moderately active,
active, highly active and resistant (Selvin and Lipton,
2004).
The secondary metabolites of U. fasciata successfully inhibited the growth of B. cereus and
E. coli to the extent of 132.66 mm 2 and 112.56 mm 2
respectively at 20°C. It was active (94.98 mm2) against
M. luteus, A. hydrophila and P. aeruginosa at 20°C
(Fig. 1). The range was extended against B. cereus
(78.5 mm 2), E. coli (98.06 mm 2) at 30°C and a clown
fish isolate, CF1 (63.58 and 94.98 mm2) at 30 and 20°C
respectively. A gram-positive bacterium, B. subtilis and
a secondary pathogenic shrimp isolate, V. alginolyticus
(QS7) were found to be moderately sensitive to U.
fasciata (50.24 and 38.46 mm2 and 38.46 and 50.24 mm2
inhibition area respectively at 30 and 20°C). The same
range of inhibition (50.24 mm 2 ) was observed in the
case of A. hydrophila and V. fischeri at 30°C whereas
opportunistic shrimp pathogen, V. harveyi (RJM5) exhibited 38.46 mm 2 inhibition at 20°C. The activity
range was reduced to less than 30 mm 2 inhibition area
against M. luteus (28.26 mm2) and RJM5 (28.26 mm2) at
30°C, V. fischeri (28.3 mm 2) at 20°C and a clown fish
isolate, CF2 (12.86 and 19.26 mm2) at both the incubation temperatures.
The secondary metabolites of H. musciformis

Table 1. Antibacterial activity of algal extracts

Source organism of

% antibacterial activity

algal extracts

Total (%)
30°C
20°C

Gram positive (%)
30°C
20°C

Gram negative (%)
30°C
20°C

Ulva fasciata
Hypnea musciformis

100
54.0

100
66.0

100
50

100
50

100
100

100
75
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Table 2. Artemia cytotoxicity profile of algal extracts at 30 and
20°C
Algal extracts

Fig. 2. Antibacterial activity of Hypenea musciformis.

showed antibacterial activity to the extent of 132.60 and
113.04 mm 2 respectively at 20°C against M. luteus and
P. aeruginosa (Fig. 2). However, M. luteus was totally
resistant at 30°C. It successfully prevented the growth
of A. hydrophila at a rate of 63.6 and 78.50 mm2 in both
the temperatures. In terms of activity range, it was
active against B. subtilis (50.24 mm2) at 20°C. However,
at 30°C, it exhibited less activity (19.62 mm 2). Such
less activity was also extended against B. cereus at both
temperatures and V. fischeri and CF1 at 30°C. The
strains such as E. coli, QS7, RJM5 and CF2 showed total
resistance to H. musciformis extract at both temperatures followed by V. fischeri and CF1 at 20°C. The

Mortality (%)

(mg/mL)

30 ± 2°C

20 ± 2°C

U. fasciata

1
2
4
6

10.2 ± 2.6
50.0 ± 7.0
91.66 ± 1.26
97.5 ± 4.8

0
20.0 ± 3.4
40.0 ± 5.6
60.0 ± 7.37

H. musciformis

1
2
4
6

20.2 ± 3.6
60.0 ± 7.0
90.6 ± 3.2
100 ± 0.0

0
0
20.0 ± 1.26
40.0 ± 2.19

Mean ± SD

Fig. 1. Antibacterial activity of Ulva fasciata.

Concentration

n=10

results clearly indicated the incubation temperature
considerably influenced the antibiosis of algal extracts.
In certain cases the activity was significantly increased
at 20°C. The slow growth rate of bacteria at 20°C may
be the reason for the increased activity of algal extracts
at low temperature. Antibiosis of algal extracts revealed that gram positive bacterial strains were more
susceptible. It was reported that the gram positive
strains were more susceptible to seaweed extracts than
gram negative bacterial strains (Rao and Parekh, 1981;
Pesando and Caram, 1984; Rosett and Srivastava, 1987).
Invariably, seaweeds have been proven to be potent source of antimicrobial compounds. This potential
have also been proved in ‘in captivity’ control of shrimp
bacterial pathogens (Selvin, 2002). Ethanolic extract of
8 species of seaweeds belonging to the groups of
Chlorophyta, Pheophyta and Rhodophyta exhibited
broad-spectrum antibacterial and antifungal activities
(de-Campos et al., 1998). The algal extracts such as
Enteropmorpha compressa, Cladophorosis zoolingeri,
Padina gymnospora, Sargassum wightii and Gracilaria
corticata were active against gram positive and gram
negative bacteria (Rao et al., 1991). Based on the
present findings, it could be inferred that the bioassay
guided fractionation and purification may come up with
potent antibacterial compounds.
Based on the brineshrimp lethality potential, the
medium lethal dose (1.8 mg/mL) extrapolated from the
graph indicated that U. fasciata extract was moderately
toxic. The LC 50 value of H. musciformis extract was
4.2 mg/mL. Temperature had significant influence on
the toxicity of algal extracts. The toxicity profile of
algal extracts considerably decreased at 20 ± 2°C (Table
2). At this temperature, the toxicity of U. fasciata
extract was reduced to 60% mortality at 6 mg/mL while
the same concentration produced 97.5% mortality at
30 ± 2°C. Schmitz et al. (1993) reported the compounds
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Table 3. Larvicidal profile of algal extracts on second and
fourth instar larvae of Culex sp.
Algal extracts

Concentration
(mg/mL)

U. fasciata

10
6
10
6

H. musciformis
Mean ± SD

Mortality (%)
Second instar Fourth instar
larvae
larvae
100 ± 0.0
60.2 ± 2.6
100 ± 0.0
61.2 ± 3.0

20.2 ± 1.72
0
10.2 ± 2.71
0

Table 5. General behavioural changes observed in Oreochromis
mossambicus exposed to ichthyotoxic algal extracts

Stages

Behavioural changes

State I:
Initial signs
Stage II:
Secondary signs
State III:
Advanced signs

a) Increased in ventilatory frequency
b) Erratic/rapid movements
a) Inclined towards one side
b) Loss of swimming activity
a) Rapid surface respiration
b) Inclined to bottom
c) Start of sporadic uncontrollable
swimming with non directional bursts

n = 10

Table 4. Ichthyotoxicity profile of algal extracts to Oreochromis mossambicus fingerlings

Species
U. fasciata

H. musciformis

Mean ± SD

Concentration (mg/mL)

Mortality (%)

Time of death (h)

8
4
2
4
2
1

100
60.4 ± 3.0
0
100
20.0 ± 2.89
0

2
6
6
6
-

n = 10

that showed activity in the brineshrimp could be correlated some extent to their potent cytotoxicity. Therefore the secondary metabolites of U. fasciata could be
used for the isolation of cytotoxic fractions. Literature
also evidenced the anticancer potentials of secondary
metabolites isolated from seaweeds (Harada et al., 1997;
Prabhadevi et al., 1998; Elena et al., 2001).
The results of larvicidal activity indicated that the
second instar larvae were more susceptible than the
fourth instar larvae (Table 3). Similar observations
were reported in the earlier works by Purohit et al.,
(1983) and Krishnamoorthy (1996). The seaweeds (U.
fasciata and H. musciformis) produced 100% mortality
at 10 mg/mL. The activity profile considerably deviated among the different larval stages. Notably the
fourth instar larvae were resistant at the concentration
that produced 100% mortality for the second instar
larvae exposed to U. fasciata and H. musciformis. The
extracts might possess larvicidal and growth regulatory
activities when the treatment was effected to different
larval stages (Rao et al., 1991). The acetone extract of
seaweeds C. scalpelliformis and Dictyota dichotoma
exhibited mosquito larvicidal activity against Aedes
aegypti (Thangam and Kathiresan, 1991). Albeit the
larvicidal potential of seaweeds was well established,
no evidence was available on the field trials of seaweedbased mosquito repellents.
The secondary metabolites of U. fasciata effec-

tively prevented the blood clotting to the extent of 120
seconds while the control blood clotted within 40
seconds. The secondary metabolites of H. musciformis
and Methanol (VC) did not significantly influence the
clotting time. It was reported that seaweeds are excellent source of anticoagulants (Lara-Isassi and Alvarez,
1995). Sulfated xylogalactam isolated from a semiperennial red alga Delesseria sanguinea and fucoidaw
from the brown algae Fucus vesiculosus and Pelvetia
canaliculata showed significant anticoagulant activity
(Nabil and Cosson, 1996; Nishino et al., 1995; Collinec
et al., 1994). The secondary metabolites of U. fasciata
were proven to be a potent immunomodulatory agent
(Selvin et al., 2004).
Antifeedant activity (ichthyotoxicity profile) of
algal extracts is presented in Table 4. U. fasciata was
toxic at 4 mg/mL while 2 mg/mL was less toxic and did
not influence mortality within 6 h. H. musciformis extract was less toxic as 20.0% mortality was recorded
only at 2 mg/mL. Both the algal extracts exhibited more
or less same sort of behavioural changes (Table 5).
Initially the fishes exhibited erratic movements and
then inclined towards one side. Later, they rapidly went
for surface respiration followed by settling at bottom or
rapid swimming activity with non-directional bursts,
which culminated in dwelling at bottom and mortality
(Indap and Pathare, 1998). The present findings suggested that the seaweeds might possess secondary me-
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tabolites to ward off predators. However in the ‘mollusc foot adherence assay’, it was found that the seaweeds
were not molluscicidal. Both species prevented the
foot adherence of limpets to extent of 70% at 10 mg/mL.
Literature indicated that the antifouling property of
seaweeds were associated with epiphytic microorganisms (Boyd et al., 1998). Based on the present findings
it could be inferred that bioassay guided fractionation
and purification of U. fasciata and H. musciformis may
give forth potent bioactive compounds.
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